Study Evaluating the Etiology of Intra-Abdominal Infections

Completed

• Conditions: Intra-abdominal Infection

• Registration Number: NCT00244088
• Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer

Brief Summary

The aim of this study is to define the etiology of intra-abdominal infections, to study the role of Enterococcus spp and Pseudomonas aeruginosa in these infections and to clarify the need for specific enterococcal antimicrobial coverage.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-04
• Primary Completion: 2004-12
• Study Completion: 2004-12
• Study First Submitted: 2005-10-21
• Study First Submitted QC: 2005-10-21
• Study First Posted: 2005-10-25
• Status Verified: 2009-08
• Last Update Submitted: 2009-08-31
• Last Update Posted: 2009-09-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 340

Inclusion Criteria

• A case will be defined as an intra-abdominal abscess or peritoneal fluid culture that will be positive for enterococcus or an enterococcal bacteriemia in association with an intra-abdominal source of infection.
• A control will be defined as a culture-positive intra-abdominal infection or bacteriemia due to an intraabdominal focus where enterococci have not been isolated.

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified